| Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth M Behdani, S Zeinali, M Karimipour, H Khanahmad, S Schoonooghe, ... New biotechnology 30 (2), 205-209, 2013 | 110 | 2013 |
| Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 108 | 2011 |
| Enhanced protective efficacy of nonpathogenic recombinant Leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 79 | 2014 |
| In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response N Seyed, F Zahedifard, S Safaiyan, E Gholami, F Doustdari, ... PLoS Negl Trop Dis 5 (9), e1295, 2011 | 71 | 2011 |
| Post-genomics and vaccine improvement for Leishmania N Seyed, T Taheri, S Rafati Frontiers in microbiology 7, 160834, 2016 | 46 | 2016 |
| Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A* 0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 … N Seyed, T Taheri, C Vauchy, M Dosset, Y Godet, A Eslamifar, I Sharifi, ... PLoS One 9 (10), e108848, 2014 | 37 | 2014 |
| Translating Observations from Leishmanization into non-Living Vaccines: The Potential of Dendritic Cell Based Vaccination Strategies against Leishmania N Seyed, NC Peters, S Rafati Frontiers in Immunology 9, 1227, 2018 | 31 | 2018 |
| Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model M Salehi, T Taheri, E Mohit, F Zahedifard, N Seyed, Y Taslimi, M Sattari, ... Immunotherapy 4 (11), 1107-1120, 2012 | 31 | 2012 |
| Insulin receptor gene mutations in Iranian patients with type II diabetes mellitus B Kazemi, N Seyed, E Moslemi, M Bandehpour, M Bikhof Torbati, ... Iranian biomedical journal 13 (3), 161-168, 2009 | 28 | 2009 |
| Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite F Zahedifard, H Lee, JH No, M Salimi, N Seyed, A Asoodeh, S Rafati Experimental Parasitology, 107823, 2019 | 27 | 2019 |
| Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice Z Abdossamadi, N Seyed, F Zahedifard, T Taheri, Y Taslimi, ... PLoS neglected tropical diseases 11 (12), e0006123, 2017 | 26 | 2017 |
| Generation of stable L. major+ EGFP-LUC and simultaneous comparison between EGFP and luciferase sensitivity T Taheri, HS Nik, N Seyed, F Doustdari, MH Etemadzadeh, ... Experimental parasitology 150, 44-55, 2015 | 23 | 2015 |
| Using recombinant chlamydia major outer membrane protein (MOMP) in ELISA diagnostic Kit M Bandehpour, N Seyed, M Shadnoush, P Pakzad, B Kazemi Iranian Journal of Biotechnology 4 (4), 239-244, 2006 | 21 | 2006 |
| Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice E Davarpanah, N Seyed, F Bahrami, S Rafati, R Safaralizadeh, T Taheri PLoS neglected tropical diseases 14 (1), e0007939, 2020 | 20 | 2020 |
| Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice Z Abdossamadi, T Taheri, N Seyed, H Montakhab-Yeganeh, F Zahedifard, ... Immunotherapy 9 (13), 1089-1102, 2017 | 19 | 2017 |
| Leishmania-based expression systems T Taheri, N Seyed, A Mizbani, S Rafati Applied microbiology and biotechnology 100, 7377-7385, 2016 | 19 | 2016 |
| Cloning and expression of hepatitis C virus core protein in pGemex-1 expression vector. B Kazemi, M Bandehpour, N Seyed, M Roozbehi, N Mosaffa Archives of Iranian medicine 11 (2), 173-178, 2008 | 18 | 2008 |
| Mammalian host defense peptides and their implication on combating Leishmania infection Z Abdossamadi, N Seyed, S Rafati Cellular Immunology 309, 23-31, 2016 | 17 | 2016 |
| Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model A Bolhassani, E Gholami, F Zahedifard, N Moradin, P Parsi, F Doustdari, ... Experimental parasitology 128 (1), 9-17, 2011 | 17 | 2011 |
| In vitro infectivity assessment by drug susceptibility comparison of recombinant Leishmania major expressing enhanced green fluorescent protein or EGFP-luciferase fused genes … S Sadeghi, N Seyed, MH Etemadzadeh, S Abediankenari, S Rafati, ... The Korean journal of parasitology 53 (4), 385, 2015 | 16 | 2015 |
